SNS-314 Phase 1 Clinical Trial

Phase 1 Study

Status: Recruiting

Focus: Cancer of an Organ Such as Lung, Pancreas, Colon, or Other Solid Organ Tissue

SNS-314 is being evaluated in patients for the first time in a Phase 1 study. Patients 18 years or older with a cancer of an organ such as lung, pancreas, colon, or other solid organ tissue who have received prior cancer treatment may be eligible for this study.

The unique identifier for this study on ClinicalTrials.gov is SPO-0011. This study is open for enrollment in the United States.

Sunesis researchers rely on science to target new and important ways of treating cancer.

Get information about our developing oncology medicines and find resources to support you in the fight against cancer.